Clinical guideline: antiepileptic drugs of choice for focal and generalized seizures in adult patients with epilepsy

  • Rivera-Castaño L
  • Sentíes-Madrid H
  • Berumen-Jaik J
  • et al.
N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The mainstay of treatment in patients with epilepsy is antiepileptic drugs (AEDs). Currently, there are a significant number of AEDs in Mexico. For the pharmacological management of the patient with epilepsy, it is important to know the pharmacoki-netics, dosage, mechanism of action, and formulations of the AED. 70-80% of patients with either focal or generalized seizures are completely seizure free on AED monotherapy. When, despite the use of AED in monotherapy, seizure freedom is not achieved, a second AED should be used; AEDs with different mechanisms of action are empirically combined for this purpose. If a patient persists in having seizures with the use of an adequate AED, at appropriate doses and with therapeutic adherence, a correct diagnosis of the seizure type and a differential diagnosis should be reconsidered, using a new clinical evaluation and auxiliary diagnostic tests.

Cite

CITATION STYLE

APA

Rivera-Castaño, L., Sentíes-Madrid, H., Berumen-Jaik, J., & Martínez-Juárez, I. E. (2021). Clinical guideline: antiepileptic drugs of choice for focal and generalized seizures in adult patients with epilepsy. Revista Mexicana de Neurociencia, 20(2). https://doi.org/10.24875/rmn.m19000027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free